Patents by Inventor CLAUDE ROUILLARD

CLAUDE ROUILLARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYSTAMINE ANALOGUES FOR THE TREATMENT OF PARKINSON'S DISEASE
    Publication number: 20140073694
    Abstract: The present invention relates to the use of cystamine analogues for the treatment of Parkinson's disease. The present invention also relates to the use of composition comprising cystamine analogues and cysteine. The present invention relates to a method for modifying the progression of Parkinson's disease comprising administering a therapeutically effective amount of at least one cystamine analogue or a pharmaceutically acceptable salt of a cystamine analogue to a patient in need thereof.
    Type: Application
    Filed: February 23, 2012
    Publication date: March 13, 2014
    Applicant: UNIVERSITE LAVAL
    Inventors: Francesca Cicchetti, Claude Rouillard, Frederic Calon
  • NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION
    Publication number: 20100298434
    Abstract: There is provided methods for the prevention of dopaminergic cell death for neuroprotection and the prevention or slow down of progression of Parkinson's disease. Particularly, the invention relates to methods for protecting and/or preventing dopaminergic cell death by the administration of a compound or agent inhibiting the translocation of Nur77 to the cytosol of dopaminergic cells. The invention also relates to methods for identifying such compounds or agents.
    Type: Application
    Filed: May 20, 2010
    Publication date: November 25, 2010
    Inventors: CLAUDE ROUILLARD, DANIEL LÉVESQUE, MARIA-GRAZIA MARTINOLI